CTCL is a rare and aggressive form of non-Hodgkin's lymphoma that originates in T-lymphocytes residing in the skin, with the most prevalent and advanced subtypes mycosis fungoides and Sézary ...

Pembrolizumab demonstrated clinical activity in patients with mycosis fungoides (MF) and Sézary syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma (CTCL), with nearly half of ...

Schaber, PhD, President and Chief Executive Officer of Soligenix. "CTCL is an incredibly difficult to treat orphan disease and remains an area of unmet medical need with a very limited number of ...